Bhaven N. Sampat
YOU?
Author Swipe
View article: Patents, Innovation, and Competition in Pharmaceuticals: The Hatch-Waxman Act After 40 Years
Patents, Innovation, and Competition in Pharmaceuticals: The Hatch-Waxman Act After 40 Years Open
A central policy issue in pharmaceuticals is how to balance the dynamic benefits of new drugs against the static benefits of low prices for existing drugs. In the United States, that balance is set by the Hatch-Waxman Act. We review the Ac…
View article: Indirect Cost Recovery in U.S. Innovation Policy: History, Evidence, and Avenues for Reform
Indirect Cost Recovery in U.S. Innovation Policy: History, Evidence, and Avenues for Reform Open
View article: Indirect Cost Recovery in U.S. Innovation Policy: History, Evidence, and Avenues for Reform
Indirect Cost Recovery in U.S. Innovation Policy: History, Evidence, and Avenues for Reform Open
View article: The Therapeutic Consequences of the War: World War II and the 20th-Century Expansion of Biomedicine
The Therapeutic Consequences of the War: World War II and the 20th-Century Expansion of Biomedicine Open
View article: The Government Patent Register: A New Resource for Measuring U.S. Government-Funded Patenting
The Government Patent Register: A New Resource for Measuring U.S. Government-Funded Patenting Open
View article: Brief of Scholars of Economics and Innovation as Amici Curiae in Support of Plaintiffs-Appellees in Massachusetts v. NIH
Brief of Scholars of Economics and Innovation as Amici Curiae in Support of Plaintiffs-Appellees in Massachusetts v. NIH Open
View article: The Therapeutic Consequences of the War: World War II and the 20th-Century Expansion of Biomedicine
The Therapeutic Consequences of the War: World War II and the 20th-Century Expansion of Biomedicine Open
View article: Using Bayh-Dole Act March-In Rights to Lower US Drug Prices
Using Bayh-Dole Act March-In Rights to Lower US Drug Prices Open
Importance In December 2023, the Biden-Harris Administration released a proposed framework for exercising government march-in rights (effectively granting compulsory licenses for those patents to generic drug makers) under the Bayh-Dole Ac…
View article: Unexpectedness in medical research
Unexpectedness in medical research Open
View article: Manual versus machine: How accurately does the Medical Text Indexer (MTI) classify different document types into disease areas?
Manual versus machine: How accurately does the Medical Text Indexer (MTI) classify different document types into disease areas? Open
The Medical Subject Headings (MeSH) thesaurus is a controlled vocabulary developed by the U.S. National Library of Medicine (NLM) for classifying journal articles. It is increasingly used by researchers studying medical innovation to class…
View article: The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update
The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update Open
In December 2023, the Biden-Harris Administration released a proposed framework for exercising government "march-in" rights on high-priced taxpayer-funded drugs.While both proponents and critics of the new rules view them as having broad s…
View article: The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update
The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update Open
View article: The Government Patent Register: A New Resource for Measuring U.S. Government-Funded Patenting
The Government Patent Register: A New Resource for Measuring U.S. Government-Funded Patenting Open
View article: Response to Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning
Response to Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning Open
View article: America, Jump-Started: World War II R&D and the Takeoff of the US Innovation System
America, Jump-Started: World War II R&D and the Takeoff of the US Innovation System Open
During World War II, the US government’s Office of Scientific Research and Development (OSRD) supported one of the largest public investments in applied R&D in US history. Using data on all OSRD-funded invention, we show this shock had a f…
View article: The NBER Orange Book Dataset: A user’s guide
The NBER Orange Book Dataset: A user’s guide Open
View article: Unexpectedness in medical research
Unexpectedness in medical research Open
Whether research funding is targetable is one of the central unresolved questions of science policy. A particular question is how often research aimed at understanding one disease or problem spills over to others. This has been a perennial…
View article: Manual versus Machine: How Accurately Does the Medical Text Indexer (MTI) Classify Different Document Types into Disease Areas?
Manual versus Machine: How Accurately Does the Medical Text Indexer (MTI) Classify Different Document Types into Disease Areas? Open
The Medical Subject Headings (MeSH) thesaurus is a controlled vocabulary developed by the U.S. National Library of Medicine (NLM) for classifying journal articles. It is increasingly used by researchers studying medical innovation to class…
View article: <b>Doubling Down:</b> Will Large Increases in the NIH Budget Promote More Meaningful Medical Innovation?
<b>Doubling Down:</b> Will Large Increases in the NIH Budget Promote More Meaningful Medical Innovation? Open
Kesselheim proposes doubling the NIH’s budget to promote clinically meaningful pharmaceutical innovation. Since the effects of a previous doubling (from 1998-2003) were mixed, I argue that policymakers should couple future budget growth wi…
View article: Second World War and the Direction of Medical Innovation
Second World War and the Direction of Medical Innovation Open
View article: Intellectual Property Rights and Pharmaceuticals: The Case of Antibiotics
Intellectual Property Rights and Pharmaceuticals: The Case of Antibiotics Open
View article: The NBER Orange Book Dataset: A User’s Guide
The NBER Orange Book Dataset: A User’s Guide Open
This paper introduces a newly digitized, open-access version of the Food and Drug Administration's "Orange Book"-a linkage between approved small-molecule drugs and the patents that protect them.The Orange Book also reports any applicable …
View article: Crisis Innovation Policy from World War II to COVID-19
Crisis Innovation Policy from World War II to COVID-19 Open
Innovation policy can be a crucial component of governments' responses to crises. Because speed is a paramount objective, crisis innovation may also require different policy tools than innovation policy in non-crisis times, raising distinc…
View article: The NBER Orange Book Dataset: A User's Guide
The NBER Orange Book Dataset: A User's Guide Open
View article: The Dynamics of Inattention in the (Baseball) Field
The Dynamics of Inattention in the (Baseball) Field Open
Recent theoretical and empirical work characterises attention as a costly resource that decision-makers allocate strategically. There has been less research on the dynamic interdependence of attention: how paying attention now may affect p…
View article: Crisis Innovation Policy from World War II to COVID-19
Crisis Innovation Policy from World War II to COVID-19 Open
Innovation policy can be a crucial component of governments' responses to crises.Because speed is a paramount objective, crisis innovation may also require different policy tools than innovation policy in non-crisis times, raising distinct…
View article: The Economics of Crisis Innovation Policy: A Historical Perspective
The Economics of Crisis Innovation Policy: A Historical Perspective Open
View article: The Economics of Crisis Innovation Policy: A Historical Perspective
The Economics of Crisis Innovation Policy: A Historical Perspective Open
Since the beginning of the COVID-19 pandemic, policymakers, researchers, and journalists have made comparisons to World War II.In 1940, a group of top U.S. science administrators organized a major coordinated research effort to support the…
View article: What Role Should Governments Play in Setting Rewards for Medical Innovation?
What Role Should Governments Play in Setting Rewards for Medical Innovation? Open
View article: The World War II Crisis Innovation Model: What Was It, and Where Does It Apply?
The World War II Crisis Innovation Model: What Was It, and Where Does It Apply? Open
World War II was one of the most acute emergencies in U.S. history, and the first where mobilizing science and technology was a major part of the government response.The U.S. Office of Scientific Research and Development (OSRD) led a far-r…